1180671-39-9Relevant academic research and scientific papers
Hepatitis c polymerase inhibitors
-
, (2017/08/25)
The invention relates to a 4,4'-bis(2-((S)-pyrrolidine-2-yl)-1H-imidazole-4-yl)biphenyl type compound and a derivative therefore. The compound disclosed by the invention is a hepatitis c virus (HCV) polymerase inhibitor, has HCV resistant activity and can
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 116, (2012/01/05)
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof; to compositions containing such compounds; and to the of such compounds as inhibitors of HCV replication.
